These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 27263863)
1. New Method for Sorting Endothelial and Neural Progenitors from Human Induced Pluripotent Stem Cells by Sedimentation Field Flow Fractionation. Faye PA; Vedrenne N; De la Cruz-Morcillo MA; Barrot CC; Richard L; Bourthoumieu S; Sturtz F; Funalot B; Lia AS; Battu S Anal Chem; 2016 Jul; 88(13):6696-702. PubMed ID: 27263863 [TBL] [Abstract][Full Text] [Related]
2. Reprogramming of Adult Peripheral Blood Cells into Human Induced Pluripotent Stem Cells as a Safe and Accessible Source of Endothelial Cells. Simara P; Tesarova L; Rehakova D; Farkas S; Salingova B; Kutalkova K; Vavreckova E; Matula P; Matula P; Veverkova L; Koutna I Stem Cells Dev; 2018 Jan; 27(1):10-22. PubMed ID: 29117787 [TBL] [Abstract][Full Text] [Related]
3. Differentiation of functional endothelial cells from human induced pluripotent stem cells: A novel, highly efficient and cost effective method. Liu X; Qi J; Xu X; Zeisberg M; Guan K; Zeisberg EM Differentiation; 2016; 92(4):225-236. PubMed ID: 27266810 [TBL] [Abstract][Full Text] [Related]
4. Neural stem cell separation from the embryonic avian olfactory epithelium by sedimentation field-flow fractionation. Comte I; Battu S; Mathonnet M; Bessette B; Lalloué F; Cardot P; Ayer-Le Lièvre C J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Nov; 843(2):175-82. PubMed ID: 16798124 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of human-induced pluripotent stem cell-derived endothelial cells in a bleomycin-induced scleroderma mouse model. Azhdari M; Baghaban-Eslaminejad M; Baharvand H; Aghdami N Stem Cell Res; 2013 May; 10(3):288-300. PubMed ID: 23396195 [TBL] [Abstract][Full Text] [Related]
6. Purification of human induced pluripotent stem cell-derived neural precursors using magnetic activated cell sorting. Rodrigues GM; Fernandes TG; Rodrigues CA; Cabral JM; Diogo MM Methods Mol Biol; 2015; 1283():137-45. PubMed ID: 25537837 [TBL] [Abstract][Full Text] [Related]
7. Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency. Polanco JC; Ho MS; Wang B; Zhou Q; Wolvetang E; Mason E; Wells CA; Kolle G; Grimmond SM; Bertoncello I; O'Brien C; Laslett AL Stem Cells; 2013 Aug; 31(8):1498-510. PubMed ID: 23728894 [TBL] [Abstract][Full Text] [Related]
8. Single-Step Plasmid Based Reprogramming of Human Dermal Fibroblasts to Induced Neural Stem Cells. Azmitia L; Capetian P Methods Mol Biol; 2018; 1842():31-41. PubMed ID: 30196399 [TBL] [Abstract][Full Text] [Related]
9. Generation of human induced pluripotent stem cell lines from human dermal fibroblasts using a non-integration system. Uhm KO; Kim SJ; Jo EH; Go GY; Choi HY; Im YS; Ha HY; Kim JH; Koo SK Stem Cell Res; 2017 May; 21():13-15. PubMed ID: 28677527 [TBL] [Abstract][Full Text] [Related]
10. Efficient differentiation of human pluripotent stem cells to endothelial progenitors via small-molecule activation of WNT signaling. Lian X; Bao X; Al-Ahmad A; Liu J; Wu Y; Dong W; Dunn KK; Shusta EV; Palecek SP Stem Cell Reports; 2014 Nov; 3(5):804-16. PubMed ID: 25418725 [TBL] [Abstract][Full Text] [Related]
11. Generation and Neuronal Differentiation of Patient-Specific Induced Pluripotent Stem Cells Derived from Niemann-Pick Type C1 Fibroblasts. Trilck M; Hübner R; Frech MJ Methods Mol Biol; 2016; 1353():233-59. PubMed ID: 25520288 [TBL] [Abstract][Full Text] [Related]
13. Long-term self-renewable feeder-free human induced pluripotent stem cell-derived neural progenitors. Nemati S; Hatami M; Kiani S; Hemmesi K; Gourabi H; Masoudi N; Alaei S; Baharvand H Stem Cells Dev; 2011 Mar; 20(3):503-14. PubMed ID: 20632795 [TBL] [Abstract][Full Text] [Related]
14. Fast astrocyte isolation by sedimentation field flow fractionation. Sarrazy V; Vedrenne N; Bordeau N; Billet F; Cardot P; Desmoulière A; Battu S J Chromatogr A; 2013 May; 1289():88-93. PubMed ID: 23566916 [TBL] [Abstract][Full Text] [Related]
15. Scaling up a chemically-defined aggregate-based suspension culture system for neural commitment of human pluripotent stem cells. Miranda CC; Fernandes TG; Diogo MM; Cabral JM Biotechnol J; 2016 Dec; 11(12):1628-1638. PubMed ID: 27754603 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the immunogenicity of human iPS cell-derived neural stem/progenitor cells in vitro. Ozaki M; Iwanami A; Nagoshi N; Kohyama J; Itakura G; Iwai H; Nishimura S; Nishiyama Y; Kawabata S; Sugai K; Iida T; Matsubayashi K; Isoda M; Kashiwagi R; Toyama Y; Matsumoto M; Okano H; Nakamura M Stem Cell Res; 2017 Mar; 19():128-138. PubMed ID: 28135684 [TBL] [Abstract][Full Text] [Related]
18. A scale out approach towards neural induction of human induced pluripotent stem cells for neurodevelopmental toxicity studies. Miranda CC; Fernandes TG; Pinto SN; Prieto M; Diogo MM; Cabral JMS Toxicol Lett; 2018 Sep; 294():51-60. PubMed ID: 29775723 [TBL] [Abstract][Full Text] [Related]
19. The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture. Tesarova L; Simara P; Stejskal S; Koutna I PLoS One; 2016; 11(6):e0157974. PubMed ID: 27336948 [TBL] [Abstract][Full Text] [Related]
20. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors. Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]